Tozaro Forms Technical Advisory Board to Boost Smart Polymer Business in Cell/Gene Therapy Bioprocessing
Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.
Related Articles
NSF board member resigns in protest of Trump policies at agency
Alondra Nelson fingers DOGE in taking an unprecedented step
Post-gastrulation amnioids as a stem cell-derived model of human extra-embryonic development
An embryonic stem cell-based 3D model that accurately recapitulates the size, morphology, and functional features of the human amnion at 4 weeks, termed the post-gastrulation…
Engineered nucleocytosolic vehicles for loading of programmable editors
Engineered nucleocytosolic vehicles for loading of programmable editors (ENVLPE) with enhanced CRISPR ribonucleoprotein (RNP) loading and stabilization enable the efficient delivery of gene-editing effectors, such…
WHO and USAID budget cuts hurt the US
View all access options to continue reading this article. C. Offord, M. Enserink, “‘It’s tectonic’: U.S. foreign aid freeze deals a blow to research around…
Watch cuttlefish communicate—with enthusiastic gestures
By moving their arms, these smart cephalopods seem to send signals via visual cues and pressure waves
Trump officials take steps toward a radically different NSF
Efforts to shrink staff, budget, and focus have alarmed members of Congress
And the winner of this year’s ‘Dance Your Ph.D.’ contest is …
Helsinki chemist’s food-themed frolic wins overall honors as other awards recognize physics laser raps, swaying leaf cells, and collective dancing takeovers
Human touch? Acoustical analysis of ancient music reconstructs tuning and intonation, elucidating aspects of human behavior
Mathematical analysis reconstructs tuning of ancient Greek and Roman music and reveals parallels with atomist philosophy.
Groups of AI Agents Spontaneously Create Their Own Lingo, Like People
A new study says groups of AI agents influence each other and can be swayed by outsiders, highlighting a blind spot in AI safety.
Make Bioprocesses More Efficient by Making Them Less Complex
Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.